Concepts (149)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Postoperative Hemorrhage | 2 | 2019 | 81 | 1.080 |
Why?
|
| Tonsillectomy | 2 | 2019 | 111 | 0.990 |
Why?
|
| Cleft Lip | 2 | 2024 | 190 | 0.770 |
Why?
|
| Cleft Palate | 2 | 2024 | 219 | 0.760 |
Why?
|
| Vagus Nerve Stimulation | 4 | 2022 | 64 | 0.640 |
Why?
|
| Leadership | 1 | 2022 | 246 | 0.630 |
Why?
|
| Ear Canal | 1 | 2015 | 9 | 0.460 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 24 | 0.460 |
Why?
|
| Ear Diseases | 1 | 2015 | 23 | 0.460 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2015 | 9 | 0.450 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2015 | 34 | 0.450 |
Why?
|
| Sildenafil Citrate | 1 | 2015 | 57 | 0.450 |
Why?
|
| Otitis Media with Effusion | 2 | 2024 | 30 | 0.440 |
Why?
|
| Middle Ear Ventilation | 2 | 2024 | 37 | 0.440 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 36 | 0.440 |
Why?
|
| Internship and Residency | 2 | 2022 | 1219 | 0.440 |
Why?
|
| Vocal Cord Paralysis | 1 | 2015 | 66 | 0.420 |
Why?
|
| Reoperation | 2 | 2019 | 841 | 0.380 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 318 | 0.370 |
Why?
|
| Pneumonia, Aspiration | 1 | 2011 | 18 | 0.340 |
Why?
|
| Turbinates | 1 | 2010 | 13 | 0.330 |
Why?
|
| Nasal Obstruction | 1 | 2010 | 16 | 0.320 |
Why?
|
| Larynx | 1 | 2011 | 72 | 0.320 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 174 | 0.320 |
Why?
|
| Rhinoplasty | 1 | 2010 | 49 | 0.300 |
Why?
|
| Trachea | 1 | 2011 | 207 | 0.300 |
Why?
|
| Macroglossia | 1 | 2008 | 2 | 0.290 |
Why?
|
| Glossectomy | 1 | 2008 | 8 | 0.290 |
Why?
|
| Device Removal | 1 | 2011 | 224 | 0.290 |
Why?
|
| Tongue | 1 | 2008 | 30 | 0.290 |
Why?
|
| Lactic Acid | 1 | 2006 | 147 | 0.230 |
Why?
|
| Polymers | 1 | 2006 | 111 | 0.220 |
Why?
|
| Audiology | 1 | 2024 | 5 | 0.220 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 5230 | 0.210 |
Why?
|
| Humans | 22 | 2024 | 130749 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2006 | 265 | 0.200 |
Why?
|
| Child | 9 | 2019 | 26213 | 0.190 |
Why?
|
| Otolaryngology | 1 | 2024 | 114 | 0.190 |
Why?
|
| Stroke Rehabilitation | 1 | 2022 | 66 | 0.180 |
Why?
|
| Retrospective Studies | 7 | 2019 | 17672 | 0.180 |
Why?
|
| Trust | 1 | 2022 | 88 | 0.170 |
Why?
|
| Surgery, Plastic | 1 | 2022 | 109 | 0.160 |
Why?
|
| Male | 13 | 2019 | 64669 | 0.160 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 554 | 0.160 |
Why?
|
| Female | 13 | 2019 | 70618 | 0.150 |
Why?
|
| Treatment Outcome | 6 | 2022 | 12908 | 0.130 |
Why?
|
| Adolescent | 7 | 2019 | 20832 | 0.130 |
Why?
|
| Epilepsy | 2 | 2022 | 878 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2017 | 176 | 0.120 |
Why?
|
| Odontogenic Tumors | 1 | 2015 | 1 | 0.120 |
Why?
|
| Hearing Tests | 1 | 2015 | 15 | 0.120 |
Why?
|
| Myxoma | 1 | 2015 | 29 | 0.110 |
Why?
|
| Hearing | 1 | 2015 | 59 | 0.110 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 7 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 146 | 0.110 |
Why?
|
| Mouth Abnormalities | 1 | 2014 | 15 | 0.110 |
Why?
|
| Syndactyly | 1 | 2014 | 23 | 0.110 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 147 | 0.110 |
Why?
|
| Apnea | 1 | 2014 | 28 | 0.110 |
Why?
|
| Maxilla | 1 | 2014 | 42 | 0.110 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 229 | 0.110 |
Why?
|
| Fingers | 1 | 2014 | 63 | 0.110 |
Why?
|
| Stroke | 1 | 2022 | 1050 | 0.110 |
Why?
|
| Head | 1 | 2015 | 112 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2021 | 1055 | 0.110 |
Why?
|
| Neck | 1 | 2015 | 143 | 0.100 |
Why?
|
| Eye Abnormalities | 1 | 2014 | 103 | 0.100 |
Why?
|
| Mandible | 1 | 2014 | 97 | 0.100 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 18 | 0.100 |
Why?
|
| Child, Preschool | 3 | 2015 | 15011 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2019 | 3113 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 731 | 0.100 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 20 | 0.100 |
Why?
|
| Knee Joint | 1 | 2014 | 169 | 0.100 |
Why?
|
| Hemangiosarcoma | 1 | 2013 | 46 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 161 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 125 | 0.090 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2013 | 85 | 0.090 |
Why?
|
| Sirolimus | 1 | 2013 | 230 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 1236 | 0.090 |
Why?
|
| Propranolol | 1 | 2011 | 110 | 0.090 |
Why?
|
| Laryngeal Neoplasms | 1 | 2011 | 85 | 0.080 |
Why?
|
| Rhinomanometry | 1 | 2010 | 2 | 0.080 |
Why?
|
| Hemangioma | 1 | 2011 | 88 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 129 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2010 | 101 | 0.080 |
Why?
|
| Syncope | 1 | 2010 | 52 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2011 | 204 | 0.080 |
Why?
|
| Laryngismus | 1 | 2009 | 4 | 0.080 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2009 | 40 | 0.080 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 973 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 618 | 0.070 |
Why?
|
| Botulinum Toxins | 1 | 2009 | 111 | 0.070 |
Why?
|
| Movement | 1 | 2008 | 143 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1478 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 397 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2010 | 318 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3869 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2006 | 26 | 0.060 |
Why?
|
| Polyesters | 1 | 2006 | 38 | 0.060 |
Why?
|
| Seizures | 1 | 2011 | 885 | 0.060 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 117 | 0.050 |
Why?
|
| Infant | 3 | 2015 | 13321 | 0.050 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 175 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2015 | 6494 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2022 | 49 | 0.050 |
Why?
|
| Hospitalization | 1 | 2011 | 1934 | 0.050 |
Why?
|
| Staphylococcus aureus | 1 | 2006 | 481 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 4933 | 0.040 |
Why?
|
| Career Choice | 1 | 2022 | 163 | 0.040 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 564 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 10021 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2022 | 199 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2013 | 4668 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2010 | 3715 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 274 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 600 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2307 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2015 | 10 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 12 | 0.030 |
Why?
|
| Chromogranins | 1 | 2015 | 30 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2013 | 30 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2013 | 131 | 0.020 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 178 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 194 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 708 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 962 | 0.020 |
Why?
|
| Biopsy | 1 | 2015 | 1241 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 427 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 994 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2014 | 650 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 698 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 673 | 0.020 |
Why?
|
| Polysomnography | 1 | 2009 | 155 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2104 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3698 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2010 | 861 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 4478 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3416 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7499 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 8565 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6146 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 11001 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6240 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 18203 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20956 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31266 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 33873 | 0.010 |
Why?
|